Abundant Produce provides operational update
Abundant Produce Limited (ASX:ABT) has provided a highly promising companywide update.
Directors remain committed
21,381,514 shares which had been under Escrow since ABT’s listing will be removed from Escrow on 26 April 2018.
Approximately 79% of these shares are owned by ABT’s Directors.
The company’s Directors have indicated that they intend to retain their holdings, and remain committed to the strategy and vision of ABT.
Abundant Natural Health (ANH)
Following up on its recent agreement with Jatenergy (JAT), ABT informed investors that it will benefit from JAT’s move to join forces with Shanghai Dragon Corporation (SDC).
JAT announced on 12 April 2018 that it had entered into a “Cooperation Letter of Intent” with SDC to work together to bring Australian products to Chinese consumers.
JAT will be the supplier of ANH’s products while SDC will oversee the import, provision of a sales platform and selling of the goods in China.
The above agreement will solidify ANH’s partnership with JAT as a result of the direct International Supply Agreement announced on 4 April 2018. The partnership is pivotal to ANH’s strategy of delivering quality Australian made and owned natural skin care products into the growing Chinese consumer market.
Overall this is an early stage play and as such any investment decision should be made with caution and professional financial advice should be sought.
SDC is a state controlled, publically listed business with over 40 years of international trading history. It also enjoys extensive logistics and warehousing infrastructure in China.
SDC has recorded sales in excess of A$1 billion (equivalent) per annum and possesses over 2,100 employees.
ANH’s CEO, Mrs Shanan Birkin, commented on the promising development, “ANH will leverage JAT’s relationship with SDC, which will be measured over the next six to 12 months by our sales revenue and brand positioning in the Chinese market.”
Abundant Seeds Pty Ltd (AS)
AS has reported that domestic cucumber seed sales have increased along the Eastern Seaboard of NSW and in Adelaide, SA.
The company believes this is due to farmers’ concerns about disease from imported varieties and their ability to fully adapt to local conditions. Increased Australian import restrictions mean that it is harder for varieties from overseas to enter Australia.
The estimated $9 million cucumber seed market is ripe for change, with AS gearing up to capitalise on this via its Australian developed, higher yield seeds that produce quality fruit and more profit to the farmer and better produce to the Australian consumer.
The company will commence the sale of its tomato seeds to the domestic market this year.
In an effort to tap into consumer’s increased education in produce origin and harvest, AS aim is to produce this seed in Australia to ensure the product is 100% Australian from concept to table.
Internationally, we now have our tomato sweetness and colour traits firmly implanted into our major distributors varieties.
Further successful trials will see direct incorporation into the current sales of this major distributors market.
AS believes by incorporating its traits into an entire portfolio of tomato varieties, the market will adopt is new variety quicker.
In addition, it has also dispatched new cucumber varieties to our distributor to test in the Middle East.
AS has also made swift progress on the technology front, announcing that it has successfully implemented new and improved software for cucumber and tomato selection, which has facilitated an acceleration in the selection process and improved its varieties with greater efficiency and speed.
Group CEO, Mr Tony Crimmins, spoke on the company’s latest update, “AS continues to supply ANH with its source product, which is intrinsic to its success.
“Importantly, we are working hard to develop new IP for vegetable seed and varieties and lifestyle nutraceuticals. With both companies working synergistically, ANH leverages the deep scientific knowledge within AS to ensure we achieve the best possible outcome for all stakeholders.”
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of Maven Capital Pty Ltd (AFSL No. 418504). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.